Stockreport

Pelthos Therapeutics Inc (PTHS) Q4 2025 Earnings Call Highlights: Prescription Surge and ... [Yahoo! Finance]

Pelthos Therapeutics Inc.  (PTHS) 
PDF Prescription Growth: 129% increase in prescriptions from 2,716 units in Q3 to 6,232 units in Q4. Cost of Goods Sold: $1.7 million in Q4 2025. SG&A Expenses: $18.5 m [Read more]